(Q53342483)

English

Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.

scientific article published in June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study. (English)

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

Yusuke Yatabe

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Mamoru Hashimoto

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Keiichiro Kaneda

3

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Kazuki Honda

4

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Yusuke Ogawa

5

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Seiji Yuuki

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Manabu Ikeda

7

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

publication date

1 June 2013

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

13

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

88-93

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Relatives of the impaired elderly: correlates of feelings of burden.

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

'Awakenings' in demented patients

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12004

21 January 2018

Identifiers

10.1111/PSYG.12004

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23909965

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53342483&oldid=1525248939"